Invion (AU:IVX) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Invion Limited has appointed Professor Robert Ramsay, a leading expert in cancer biology, as its Scientific Advisor to guide its clinical trials and research programs. Ramsay’s expertise, particularly with Invion’s lead cancer drug candidate INV043, is expected to enhance the company’s efforts in advancing Photodynamic Therapy for cancer treatment. This strategic move aligns with Invion’s mission to develop life-changing therapies and address unmet needs in patient care.
For further insights into AU:IVX stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue